JPS5735587A - Benzoguanamine derivative - Google Patents

Benzoguanamine derivative

Info

Publication number
JPS5735587A
JPS5735587A JP7587580A JP7587580A JPS5735587A JP S5735587 A JPS5735587 A JP S5735587A JP 7587580 A JP7587580 A JP 7587580A JP 7587580 A JP7587580 A JP 7587580A JP S5735587 A JPS5735587 A JP S5735587A
Authority
JP
Japan
Prior art keywords
triazine
crystals
benzoguanamine derivative
dioxane
refulxed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP7587580A
Other languages
English (en)
Other versions
JPS632264B2 (ja
Inventor
Shingo Matsumura
Hiroshi Enomoto
Yoshiaki Aoyanagi
Yoshihisa Shibata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Shinyaku Co Ltd
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Priority to JP7587580A priority Critical patent/JPS5735587A/ja
Priority to KR1019800004342A priority patent/KR840001939B1/ko
Priority to GB8114585A priority patent/GB2078214B/en
Priority to US06/266,483 priority patent/US4333933A/en
Priority to IT48567/81A priority patent/IT1171258B/it
Priority to CH3576/81A priority patent/CH648033A5/de
Priority to DE3121922A priority patent/DE3121922C2/de
Priority to FR8111008A priority patent/FR2483919A1/fr
Publication of JPS5735587A publication Critical patent/JPS5735587A/ja
Priority to KR1019840004723A priority patent/KR840001953B1/ko
Publication of JPS632264B2 publication Critical patent/JPS632264B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
    • C07D251/16—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
    • C07D251/16—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
    • C07D251/18—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with nitrogen atoms directly attached to the two other ring carbon atoms, e.g. guanamines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP7587580A 1980-06-04 1980-06-04 Benzoguanamine derivative Granted JPS5735587A (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
JP7587580A JPS5735587A (en) 1980-06-04 1980-06-04 Benzoguanamine derivative
KR1019800004342A KR840001939B1 (ko) 1980-06-04 1980-11-13 벤조구아나민 유도체의 제조방법
GB8114585A GB2078214B (en) 1980-06-04 1981-05-13 Benzoguanamine derivatives
US06/266,483 US4333933A (en) 1980-06-04 1981-05-22 Benzoguanamine derivatives, their production and pharmaceutical compositions containing the same
IT48567/81A IT1171258B (it) 1980-06-04 1981-05-28 Derivati della benzoguanammina procedimento per la loro produzione e composizioni farmaceutiche che li contengono
CH3576/81A CH648033A5 (de) 1980-06-04 1981-06-01 Benzoguanamin-derivate, deren herstellung und pharmazeutische zusammensetzungen, welche diese verbindungen enthalten.
DE3121922A DE3121922C2 (de) 1980-06-04 1981-06-02 2-Amino-4-nicotinoylamino-6-halogenphenyl-s-triazine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
FR8111008A FR2483919A1 (fr) 1980-06-04 1981-06-03 Procede de production de derives de benzoguanamine, nouveaux produits ainsi obtenus et compositions pharmaceutiques a action anti-inflammatoire les contenant
KR1019840004723A KR840001953B1 (ko) 1980-06-04 1984-08-08 벤조구아나민 유도체의 제조법

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7587580A JPS5735587A (en) 1980-06-04 1980-06-04 Benzoguanamine derivative

Publications (2)

Publication Number Publication Date
JPS5735587A true JPS5735587A (en) 1982-02-26
JPS632264B2 JPS632264B2 (ja) 1988-01-18

Family

ID=13588878

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7587580A Granted JPS5735587A (en) 1980-06-04 1980-06-04 Benzoguanamine derivative

Country Status (8)

Country Link
US (1) US4333933A (ja)
JP (1) JPS5735587A (ja)
KR (2) KR840001939B1 (ja)
CH (1) CH648033A5 (ja)
DE (1) DE3121922C2 (ja)
FR (1) FR2483919A1 (ja)
GB (1) GB2078214B (ja)
IT (1) IT1171258B (ja)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2615393A1 (fr) * 1987-05-20 1988-11-25 Nippon Shinyaku Co Ltd Agent nootrope a base de 2-amino-4-nicotinoylamino-s-triazine
JPH0542265A (ja) * 1991-08-15 1993-02-23 Kaijirushi Hamono Kaihatsu Center:Kk 二枚刃安全かみそり
WO1996004914A1 (fr) * 1994-08-08 1996-02-22 Nippon Shinyaku Co., Ltd. Derive de triazine et medicament
WO1996028164A1 (fr) * 1995-03-09 1996-09-19 Nippon Shinyaku Co., Ltd. Medicament contre la pancreatite
WO1996032945A1 (fr) * 1995-04-20 1996-10-24 Nippon Shinyaku Co., Ltd. Inhibiteur de neovascularisation

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57203083A (en) * 1981-06-05 1982-12-13 Nippon Shinyaku Co Ltd Nicotinic acid derivative
JPS59106473A (ja) * 1982-12-10 1984-06-20 Nippon Shinyaku Co Ltd トリアジン誘導体
US5962453A (en) * 1995-08-08 1999-10-05 Nippon Shinyaku Co. Ltd. Triazine derivative and medicine
WO1999001442A1 (en) * 1997-07-02 1999-01-14 Zeneca Limited Triazine derivatives and their use as antibacterial agents
WO2005030735A1 (en) * 2003-09-25 2005-04-07 Ranbaxy Laboratories Limited Triazines derivatives as cell adhesion inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52118483A (en) * 1976-03-29 1977-10-04 Nippon Shinyaku Co Ltd Nicotinylaminotriazine derivatives
US4291162A (en) * 1979-07-25 1981-09-22 Ciba-Geigy Corporation Aminotriazinepolycarboxylic acids and partial esters thereof

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2615393A1 (fr) * 1987-05-20 1988-11-25 Nippon Shinyaku Co Ltd Agent nootrope a base de 2-amino-4-nicotinoylamino-s-triazine
JPH0542265A (ja) * 1991-08-15 1993-02-23 Kaijirushi Hamono Kaihatsu Center:Kk 二枚刃安全かみそり
WO1996004914A1 (fr) * 1994-08-08 1996-02-22 Nippon Shinyaku Co., Ltd. Derive de triazine et medicament
WO1996028164A1 (fr) * 1995-03-09 1996-09-19 Nippon Shinyaku Co., Ltd. Medicament contre la pancreatite
US5885993A (en) * 1995-03-09 1999-03-23 Nippon Shinyaku Company, Limited Remedy for pancreatitis
WO1996032945A1 (fr) * 1995-04-20 1996-10-24 Nippon Shinyaku Co., Ltd. Inhibiteur de neovascularisation
US5962454A (en) * 1995-04-20 1999-10-05 Nippon Shinyaku Co., Ltd. Neovascularization inhibitor

Also Published As

Publication number Publication date
IT1171258B (it) 1987-06-10
KR830004292A (ko) 1983-07-09
US4333933A (en) 1982-06-08
DE3121922A1 (de) 1982-02-25
GB2078214A (en) 1982-01-06
KR850002014A (ko) 1985-04-10
IT8148567A0 (it) 1981-05-28
JPS632264B2 (ja) 1988-01-18
FR2483919A1 (fr) 1981-12-11
KR840001939B1 (ko) 1984-10-25
KR840001953B1 (ko) 1984-10-26
GB2078214B (en) 1984-04-11
CH648033A5 (de) 1985-02-28
DE3121922C2 (de) 1982-10-14
FR2483919B1 (ja) 1984-11-30

Similar Documents

Publication Publication Date Title
JPS5735587A (en) Benzoguanamine derivative
IL59760A0 (en) 7-oxo-4-thia-1-aza-bicyclo(3,2,0)-heptane-2-carboxylic acid derivatives,and process for their preparation
JPS5354295A (en) Preparation of polyester
JPS5271433A (en) Preparation of aromatic polycarboxylic acid arylester
JPS52128387A (en) Preparation of tris (2-hydroxyethyl) isocyanurate derivatives
JPS51138670A (en) Process for preparing phthalimide derivatives
JPS55164682A (en) 1-alkyl-2-oxo-2h-1,8-naphthyridine derivative and its preparation
JPS565490A (en) Preparation of amine-borane
DE3061742D1 (en) Substituted 2,2-dimethylpentane (ene)-1-carboxylic acid derivatives, process for their preparation and their use for the preparation of styryl-cyclopropane-carboxylates
JPS525755A (en) Process for preparation of 3-amino-4-homotwistane and its acid salts
JPS5398944A (en) 6-substituted-3,4-dihydronaphthalene-2-acetic acid derivatives and process for their preparation
JPS5248622A (en) Process for preparation of fatty acid ester derivatives
JPS5371033A (en) Preparation of 4-alkoxycarbonyl-3,5-dimethylphthalic acid anhydride
JPS51141855A (en) Process for preparing exo-hydroxy-endo-tricyclo-(5,2,2,02,6)undecane
JPS5242867A (en) Process for preparation of 17alpha -(3-hydroxypropyl)- 17beta-hydroxy-androsto- 4 -ene-3-one
JPS51127056A (en) Process for preparation of naphthalene-2, 6-dicarboxylic acid-(2, 6 ) and its alkylesters
JPS51136659A (en) Process for preparation of naphthalene-2, 6-dicalboxylic acid and its alkylesters
JPS5432476A (en) Preparation of 3-aminopyridines
JPS51141895A (en) Process for preparing 1,4-diaza-bicyclo(2,2,2)octane
JPS5765755A (en) Preparation of copper phthalocyanine pigment
JPS543021A (en) Novel derivative of glutamic acid and its preparation
JPS51136628A (en) Process for preparing benzylalchol derivatives
JPS55136280A (en) Substituted piperazine compound and its preparation
DE3061527D1 (en) Derivatives of the mercaptopropionamido-acetic acid, process for the preparation thereof and compositions
JPS5655380A (en) iso cyanurate ring-containing azide compound and its preparation